Titre : Symporteurs des ions sodium-potassium-chlorure

Symporteurs des ions sodium-potassium-chlorure : Questions médicales fréquentes

Termes MeSH sélectionnés :

Controlled Substances
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Symporteurs des ions sodium-potassium-chlorure : Questions médicales les plus fréquentes", "headline": "Symporteurs des ions sodium-potassium-chlorure : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Symporteurs des ions sodium-potassium-chlorure : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-13", "dateModified": "2025-03-08", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Symporteurs des ions sodium-potassium-chlorure" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines transporteurs de solutés", "url": "https://questionsmedicales.fr/mesh/D000070590", "about": { "@type": "MedicalCondition", "name": "Protéines transporteurs de solutés", "code": { "@type": "MedicalCode", "code": "D000070590", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.585.937" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Membre-1 de la famille-12 des transporteurs de solutés", "alternateName": "Solute Carrier Family 12, Member 1", "url": "https://questionsmedicales.fr/mesh/D064466", "about": { "@type": "MedicalCondition", "name": "Membre-1 de la famille-12 des transporteurs de solutés", "code": { "@type": "MedicalCode", "code": "D064466", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.585.937.875.500" } } }, { "@type": "MedicalWebPage", "name": "Membre-2 de la famille-12 des transporteurs de solutés", "alternateName": "Solute Carrier Family 12, Member 2", "url": "https://questionsmedicales.fr/mesh/D064506", "about": { "@type": "MedicalCondition", "name": "Membre-2 de la famille-12 des transporteurs de solutés", "code": { "@type": "MedicalCode", "code": "D064506", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.585.937.875.625" } } }, { "@type": "MedicalWebPage", "name": "Membre-3 de la famille-12 des transporteurs de solutés", "alternateName": "Solute Carrier Family 12, Member 3", "url": "https://questionsmedicales.fr/mesh/D064486", "about": { "@type": "MedicalCondition", "name": "Membre-3 de la famille-12 des transporteurs de solutés", "code": { "@type": "MedicalCode", "code": "D064486", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.585.937.875.750" } } }, { "@type": "MedicalWebPage", "name": "Membre-4 de la famille-12 des transporteurs de solutés", "alternateName": "Solute Carrier Family 12, Member 4", "url": "https://questionsmedicales.fr/mesh/D064507", "about": { "@type": "MedicalCondition", "name": "Membre-4 de la famille-12 des transporteurs de solutés", "code": { "@type": "MedicalCode", "code": "D064507", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.585.937.875.875" } } } ], "about": { "@type": "MedicalCondition", "name": "Symporteurs des ions sodium-potassium-chlorure", "alternateName": "Sodium-Potassium-Chloride Symporters", "code": { "@type": "MedicalCode", "code": "D028021", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Robert A Fenton", "url": "https://questionsmedicales.fr/author/Robert%20A%20Fenton", "affiliation": { "@type": "Organization", "name": "Department of Biomedicine, Aarhus University, Aarhus, Denmark." } }, { "@type": "Person", "name": "Juan Pablo Nicola", "url": "https://questionsmedicales.fr/author/Juan%20Pablo%20Nicola", "affiliation": { "@type": "Organization", "name": "Department of Clinical Biochemistry, National University of Córdoba, Córdoba, Argentina." } }, { "@type": "Person", "name": "Rebekka Spellerberg", "url": "https://questionsmedicales.fr/author/Rebekka%20Spellerberg", "affiliation": { "@type": "Organization", "name": "Department of Internal Medicine IV, University Hospital, LMU Munich, 81377 Munich, Germany." } }, { "@type": "Person", "name": "Carolin Kitzberger", "url": "https://questionsmedicales.fr/author/Carolin%20Kitzberger", "affiliation": { "@type": "Organization", "name": "Department of Internal Medicine IV, University Hospital, LMU Munich, 81377 Munich, Germany." } }, { "@type": "Person", "name": "Peter J Nelson", "url": "https://questionsmedicales.fr/author/Peter%20J%20Nelson", "affiliation": { "@type": "Organization", "name": "Department of Internal Medicine IV, University Hospital, LMU Munich, 81377 Munich, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.", "datePublished": "2022-08-17", "url": "https://questionsmedicales.fr/article/35987353", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.neuropharm.2022.109220" } }, { "@type": "ScholarlyArticle", "name": "Concordance between controlled substance receipt and post-mortem toxicology in opioid-detected overdose deaths: A statewide analysis.", "datePublished": "2023-01-30", "url": "https://questionsmedicales.fr/article/36738634", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.drugalcdep.2023.109788" } }, { "@type": "ScholarlyArticle", "name": "The impact of scheduling ketamine as an internationally controlled substance on anaesthesia care in Sub-Saharan Africa: a case study and key informant interviews.", "datePublished": "2024-05-07", "url": "https://questionsmedicales.fr/article/38715038", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12913-024-11040-w" } }, { "@type": "ScholarlyArticle", "name": "Impact of mandatory COVID-19 shelter-in-place order on controlled substance use among rural versus urban communities in the United States.", "datePublished": "2022-06-16", "url": "https://questionsmedicales.fr/article/35710976", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jrh.12688" } }, { "@type": "ScholarlyArticle", "name": "Cardiopulmonary and muscular effects of different doses of high-intensity physical training in substance use disorder patients: study protocol for a block allocated controlled endurance and strength training trial in an inpatient setting.", "datePublished": "2022-09-27", "url": "https://questionsmedicales.fr/article/36167363", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2022-061014" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines membranaires", "item": "https://questionsmedicales.fr/mesh/D008565" }, { "@type": "ListItem", "position": 5, "name": "Protéines de transport membranaire", "item": "https://questionsmedicales.fr/mesh/D026901" }, { "@type": "ListItem", "position": 6, "name": "Protéines transporteurs de solutés", "item": "https://questionsmedicales.fr/mesh/D000070590" }, { "@type": "ListItem", "position": 7, "name": "Symporteurs des ions sodium-potassium-chlorure", "item": "https://questionsmedicales.fr/mesh/D028021" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Symporteurs des ions sodium-potassium-chlorure - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Symporteurs des ions sodium-potassium-chlorure", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Symporteurs des ions sodium-potassium-chlorure", "description": "Comment diagnostiquer une dysfonction des symporteurs ?\nQuels examens sont utilisés pour évaluer les symporteurs ?\nQuels symptômes indiquent une anomalie des symporteurs ?\nPeut-on détecter des mutations génétiques liées aux symporteurs ?\nQuel rôle joue l'imagerie dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D028021?mesh_terms=Controlled+Substances&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Symporteurs des ions sodium-potassium-chlorure", "description": "Quels symptômes sont liés à une défaillance des symporteurs ?\nComment se manifestent les déséquilibres électrolytiques ?\nLes symptômes varient-ils selon l'âge ?\nQuels signes cliniques sont observés ?\nLes symptômes sont-ils réversibles ?", "url": "https://questionsmedicales.fr/mesh/D028021?mesh_terms=Controlled+Substances&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Symporteurs des ions sodium-potassium-chlorure", "description": "Comment prévenir les déséquilibres électrolytiques ?\nLes exercices physiques influencent-ils les symporteurs ?\nQuels aliments sont bénéfiques pour les symporteurs ?\nFaut-il surveiller les médicaments diurétiques ?\nLes contrôles médicaux réguliers sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D028021?mesh_terms=Controlled+Substances&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Symporteurs des ions sodium-potassium-chlorure", "description": "Quels traitements sont disponibles pour les déséquilibres ?\nComment les diurétiques affectent-ils les symporteurs ?\nLes traitements sont-ils personnalisés ?\nQuel rôle joue l'hydratation dans le traitement ?\nLes thérapies géniques sont-elles une option ?", "url": "https://questionsmedicales.fr/mesh/D028021?mesh_terms=Controlled+Substances&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Symporteurs des ions sodium-potassium-chlorure", "description": "Quelles complications peuvent survenir ?\nLes complications sont-elles graves ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles évitables ?\nQuel suivi est nécessaire après des complications ?", "url": "https://questionsmedicales.fr/mesh/D028021?mesh_terms=Controlled+Substances&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Symporteurs des ions sodium-potassium-chlorure", "description": "Quels sont les facteurs de risque des déséquilibres ?\nL'âge influence-t-il le risque de déséquilibres ?\nLe stress a-t-il un impact sur les symporteurs ?\nLes maladies chroniques augmentent-elles le risque ?\nLes habitudes de vie influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D028021?mesh_terms=Controlled+Substances&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction des symporteurs ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et urinaires peuvent évaluer les niveaux d'électrolytes et la fonction rénale." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer les symporteurs ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'électrophorèse et les tests de fonction rénale aident à évaluer l'activité des symporteurs." } }, { "@type": "Question", "name": "Quels symptômes indiquent une anomalie des symporteurs ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des déséquilibres électrolytiques peuvent provoquer fatigue, crampes et troubles cardiaques." } }, { "@type": "Question", "name": "Peut-on détecter des mutations génétiques liées aux symporteurs ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests génétiques peuvent identifier des mutations affectant les symporteurs ioniques." } }, { "@type": "Question", "name": "Quel rôle joue l'imagerie dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie peut aider à évaluer les organes affectés par des déséquilibres ioniques." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une défaillance des symporteurs ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent déshydratation, hypertension, et troubles neurologiques." } }, { "@type": "Question", "name": "Comment se manifestent les déséquilibres électrolytiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent se manifester par des crampes musculaires, des palpitations et de la confusion." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants et les personnes âgées peuvent présenter des symptômes différents." } }, { "@type": "Question", "name": "Quels signes cliniques sont observés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "On peut observer une faiblesse musculaire, des nausées et des troubles de la conscience." } }, { "@type": "Question", "name": "Les symptômes sont-ils réversibles ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, avec un traitement approprié, de nombreux symptômes peuvent être réversibles." } }, { "@type": "Question", "name": "Comment prévenir les déséquilibres électrolytiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et une hydratation adéquate aident à prévenir les déséquilibres." } }, { "@type": "Question", "name": "Les exercices physiques influencent-ils les symporteurs ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier aide à maintenir un bon équilibre électrolytique." } }, { "@type": "Question", "name": "Quels aliments sont bénéfiques pour les symporteurs ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les aliments riches en potassium, sodium et chlorure, comme les bananes, sont bénéfiques." } }, { "@type": "Question", "name": "Faut-il surveiller les médicaments diurétiques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est important de surveiller l'utilisation des diurétiques pour éviter les déséquilibres." } }, { "@type": "Question", "name": "Les contrôles médicaux réguliers sont-ils nécessaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des contrôles réguliers aident à détecter précocement les déséquilibres électrolytiques." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les déséquilibres ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des suppléments d'électrolytes et des médicaments diurétiques." } }, { "@type": "Question", "name": "Comment les diurétiques affectent-ils les symporteurs ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les diurétiques inhibent les symporteurs, augmentant l'excrétion d'eau et d'électrolytes." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements sont souvent adaptés en fonction des besoins individuels du patient." } }, { "@type": "Question", "name": "Quel rôle joue l'hydratation dans le traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne hydratation est essentielle pour maintenir l'équilibre électrolytique." } }, { "@type": "Question", "name": "Les thérapies géniques sont-elles une option ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches sont en cours sur les thérapies géniques pour corriger les mutations des symporteurs." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des arythmies cardiaques, des convulsions et des défaillances organiques." } }, { "@type": "Question", "name": "Les complications sont-elles graves ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines complications peuvent être potentiellement mortelles si non traitées." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent entraîner des limitations physiques et des troubles psychologiques." } }, { "@type": "Question", "name": "Les complications sont-elles évitables ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être évitées par une gestion proactive des déséquilibres." } }, { "@type": "Question", "name": "Quel suivi est nécessaire après des complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier est essentiel pour surveiller les effets à long terme." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque des déséquilibres ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent une alimentation déséquilibrée, des maladies rénales et des médicaments." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de déséquilibres ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées sont plus susceptibles de développer des déséquilibres électrolytiques." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur les symporteurs ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut affecter l'équilibre électrolytique et la fonction des symporteurs." } }, { "@type": "Question", "name": "Les maladies chroniques augmentent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme le diabète et l'hypertension augmentent le risque de déséquilibres." } }, { "@type": "Question", "name": "Les habitudes de vie influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes comme le tabagisme et l'alcoolisme peuvent augmenter le risque." } } ] } ] }

Sources (10000 au total)

Concordance between controlled substance receipt and post-mortem toxicology in opioid-detected overdose deaths: A statewide analysis.

Opioid overdoses are a leading cause of preventable death in the United States. There is limited research linking decedents' receipt of controlled substances and presence of controlled substances on p... We linked data on opioid-detected deaths in Connecticut between May 3, 2016, and December 31, 2017 from the Office of the Chief Medical Examiner, Department of Consumer Protection, and Department of M... Our analysis included 1412 opioid-detected overdose deaths. 47 % received an opioid or benzodiazepine 90 days prior to death; 36 % received an opioid and 27 % received a benzodiazepine. Concordance be... Our results suggest medically supplied opioids and benzodiazepines potentially contributed to a substantial number, though minority, of opioid-detected deaths during the study period. Efforts to reduc...

The impact of scheduling ketamine as an internationally controlled substance on anaesthesia care in Sub-Saharan Africa: a case study and key informant interviews.

Access to anaesthesia and surgical care is a major problem for people living in Sub-Saharan Africa. In this region, ketamine is critical for the provision of anaesthesia care. However, efforts to cont... This research is a mixed-methods study, comprising of a cross-sectional survey at the hospital level in Rwanda, and key informant interviews with experts on anaesthesia care in Sub-Saharan Africa. Dat... The survey conducted in Rwanda found that availability of ketamine and propofol was comparable at around 80%, while thiopental and inhalational agents were available at only about half of the hospital... Ketamine is critical for the provision of anaesthesia care in Sub-Saharan Africa, and its scheduling would have a significantly negative impact on its availability for anaesthesia care....

Impact of mandatory COVID-19 shelter-in-place order on controlled substance use among rural versus urban communities in the United States.

Mandatory COVID-19 shelter-in-place (SIP) orders have been imposed to fight the pandemic. They may also have led to unintended consequences of increased use of controlled substances especially among r... Call counts received by the poison control centers between October 19, 2019 and July 6, 2020 due to exposure to controlled substance (methamphetamine, opioids, cocaine, benzodiazepines, and other narc... During the study period, 2,649 counties in the United States had mandatory SIP orders. The rate of calls reporting exposure to any of the aforementioned controlled substances among the rural counties ... The mandatory SIP orders may have had an unintended consequence of exacerbating the use of controlled substances at home in rural communities relative to urban communities....

Cardiopulmonary and muscular effects of different doses of high-intensity physical training in substance use disorder patients: study protocol for a block allocated controlled endurance and strength training trial in an inpatient setting.

Patients with substance use disorder (SUD) have high prevalence of lifestyle-related comorbidities. Physical exercise is known to yield substantial prophylactic impact on disease and premature mortali... This study will recruit 40 in-patients of mixed genders, aged 18-70 years. Participants will be block allocated to low-dose or high-dose training, encompassing 24 high-intensity interval and maximal s... This protocol is in accordance with the Standard Protocol Items: Recommendations for Interventional Trials statement. All participants will sign a written informed consent. The Regional Committee of M... NCT04065334....

Acute, chronic, and post-mortem toxicity: a review focused on three different classes of new psychoactive substances.

New psychoactive substances (NPS) are not controlled under the Single Convention on Narcotic Drugs of 1961 or the 1971 Convention, but they may pose a public health threat. Knowledge of the main prope... We carried out a literature review collecting information on the acute, chronic, and post-mortem toxicity of these classes of NSP. We searched info in five scientific databases considering works from ... Results have shown a general lack of studies in this field given that many NPS have not had their toxicity evaluated. We observed a significant difference in the volume of data concerning acute and ch... More in-depth information about the main threats involving NPS use are needed....

Does electronic prescribing of controlled substances deter controlled substance prescribing in emergency departments?

To examine the association between electronic prescribing of controlled substances (EPCS) and controlled substance prescription patterns in U.S. emergency departments (ED).... We conducted cross-sectional analysis at both the ED level and visit level, using the 2016-2017 National Hospital Ambulatory Medical Care Surveys.... The sample included 24,296 visits to 316 EDs, 45% of which utilized EPCS. Pain-related visits were associated with significantly higher odds of prescriptions for any controlled substances (OR = 1.52; ... While EPCS transmits prescriptions directly to pharmacies in order to reduce drug diversion problems, the results indicated no significant association between EPCS use and prescriptions for Schedule I... EPCS does not appear to deter Schedule II controlled substances prescription including opioids in an ED visit. It may facilitate any and Schedule III controlled substance prescriptions when pain was i...